Home/Filings/4/0001209191-23-003934
4//SEC Filing

THEUER CHARLES 4

Accession 0001209191-23-003934

CIK 0001394319other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 6:05 AM ET

Size

5.2 KB

Accession

0001209191-23-003934

Insider Transaction Report

Form 4
Period: 2023-01-18
THEUER CHARLES
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2023-01-18$1.62/sh+6,800$11,016339,918 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6065 to $1.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Issuer

Tracon Pharmaceuticals, Inc.

CIK 0001394319

Entity typeother

Related Parties

1
  • filerCIK 0001631338

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 6:05 AM ET
Size
5.2 KB